FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law

Similar documents
How patents work An introduction for law students

Dawn of an English Doctrine of Equivalents: immaterial variants infringe

The Same Invention or Not the Same Invention? Thorsten Bausch

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position

Doctrine of Equivalents: Recent Developments in Germany

Claim interpretation by the Boards of Appeal of the EPO

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -

IPFocus LIFE SCIENCES 9TH EDITION WHEN IS POST-PUBLISHED EVIDENCE ACCEPTABLE? VALEA

Title: The patentability criterion of inventive step / non-obviousness

Patent litigation. Block 1. Module Priority. Essentials: Priority. Introduction

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness

Claims and Determining Scope of Protection

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

English Language Translation Entry into New Zealand PCT National Phase

Amendments in Europe and the United States

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility

Evidence in EPO Proceedings. Dr. Joachim Renken Madrid, November 14, 2016

Unity of inventions at the EPO - Amendments to rule 29 EPC

Art. 123(2) EPC ADDED MATTER A US Perspective. by Enrica Bruno Patent Attorney. Steinfl & Bruno LLP Intellectual Property Law

Drafting international applications with Europe in mind. Dr. Matthew Barton, UK and European patent attorney, Forresters

SEEKING THE GOLD (STANDARD) Amendments before EPO. Marco Lissandrini European Patent Attorney

EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT)

Allowability of disclaimers before the European Patent Office

The opposition procedure and limitation and revocation procedures

The Netherlands Pays Bas Niederlande. Report Q189. in the name of the Dutch Group

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University

publicly outside for the

CA/PL 7/99 Orig.: German Munich, SUBJECT: Revision of the EPC: Articles 52(4) and 54(5) President of the European Patent Office

Guidebook. for Japanese Intellectual Property System 2 nd Edition

AIPPI Study Question - Patentability of computer implemented inventions

An introduction to European intellectual property rights

Patent Claims. Formal requirements and allowable amendments. 2005Jaroslav Potuznik

11th Annual Patent Law Institute

Switzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules

Aligning claim drafting and filing strategies to optimize protection in the EPO, GPTO and USPTO

Criteria for Patentability

Intellectual Property and crystalline forms. How to get a European Patent on crystalline forms?

Eli Lilly v Actavis. Mark Engelman Head of Intellectual Property

Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector

COMPARATIVE STUDY REPORT REQUIREMENTS FOR DISCLOSURE AND CLAIMS - 1 -

Chapter Patent Infringement --

Second medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines

The European Patent Office An overview on the procedures before the EPO: up to grant, opposition and appeal

Note concerning the Patentability of Computer-Related Inventions

Title: The patentability criterion of inventive step / non-obviousness

The use of prosecution history in post-grant patent proceedings

S A M P L E Q U E S T I O N S April 2002

Chapter 1 Requirements for Description

Harmonisation across Europe - comparison and interaction between the EPO appeal system and the national judicial systems

Part II. Time limit for completing the International search. Application not searched

Selection Inventions the Inventive Step Requirement, other Patentability Criteria and Scope of Protection

The European Patent Office

The EPO Enlarged Board of Appeal decides on dosage regimens (G2/08) and treatment by surgery (G1/07)

AIPPI REPORT OF THE NETHERLANDS GROUP ON 2016 STUDY QUESTION (PA- TENTS) ADDED MATTER: THE STANDARD FOR DETERMINING ADEQUATE SUPPORT FOR AMENDMENTS

Where are we now with plausibility?

PATENT DISCLOSURE: Meeting Expectations in the USPTO

Designing Around Valid U.S. Patents Course Syllabus

Fordham 2008 Comparative Obviousness

European Patents. Page 1 of 6

G3/08 PATENTABILITY OF SOFTWARE : DETAILS EXPECTED FROM

Patenting Software-related Inventions according to the European Patent Convention

Summary Report. Report Q189

Disclaimers at the EPO

New Decisions of the Technical Boards of Appeal. Dr. Leonard Werner-Jones Dr. Ursula Kinkeldey (Retired Chairwoman Board of Appeal)

Intellectual Property Department Hong Kong, China. Contents

CUSTOMER CONTRACT REQUIREMENTS A-160 HUMMINGBIRD CUSTOMER CONTRACT N

Outline of the Examination Guidelines for Patent and Utility Model. Examination Standards Office Japan Patent Office

Second medical use or indication claims. [Please insert name last name in CAPITAL letters please]

Recent Situation of the Japanese Intellectual Property Protection Scheme

4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA

Added matter under the EPC. Chris Gabriel Examiner Directorate 1222

COMMENTARY. Antidote to Toxic Divisionals European Patent Office Rules on Partial Priorities. Summary of the Enlarged Board of Appeal s Decision

pct2ep.com Guide to claim amendment after EPO regional phase entry

Recent EPO Decisions: Part 1

Europe Divided Update on National Case Law in Europe

11th Annual Patent Law Institute

DETAILED TABLE OF CONTENTS

Deputy Commissioner for Patent Examination Policy

Threats & Opportunities in Proceedings before the EPO with a brief update on the Unitary Patent

SHORT GUIDE ON PATENTS

Partial Priorities and Transfer of Priority Rights. Dr. Joachim Renken

2016 Study Question (Patents)

Patents Act 1977, Secs. 3, 60, 125 ; European Patent Convention, Protocol on the Interpretation of Art "Kastner"

STATUS AND APPLICATIONS

Netherlands. Report Q 175

Claiming what counts in business: drafting patent claims with a clear business purpose

RECENT CASE LAW OF THE EPO REGARDING SOFTWARE/BUSINESS METHOD- RELATED INVENTIONS

Chemical Patent Practice. Course Syllabus

FC3 (P5) International Patent Law 2 FINAL Mark Scheme 2017

ARE EXPRESSED SEQUENCE TAGS PATENTABLE UNDER THE EUROPEAN PATENT CONVENTION? A PRACTITIONER'S VIEW

Intellectual Property Teaching Kit IP Advanced Part I

PROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION

Patent Prosecution Procedures under the Japanese Patent Law. Sera, Toyama, Matsukura & Kawaguchi

Patent Resources Group. Chemical Patent Practice. Course Syllabus

Summary and Conclusions

The use of prosecution history in post-grant patent proceedings. Maria CRUZ GARCIA, Isabel FRANCO, João JORGE, Teresa SILVA GARCIA

should disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art

ROMANIA Patent Law NO.64/1991 OFFICIAL GAZETTE OF ROMANIA, PART I, NO.613/19 AUGUST 2014

Enhancement of Attraction of Utility Model System

WSPLA (Wash. State Patent Law Assoc.) Lunch Seminar

Transcription:

FUNCTIONAL CLAIMING UNDER THE EPC General principles and case-law Elisabetta Papa Società Italiana Brevetti S.p.A.

Functional claiming is allowed under the EPC and related case-law, with a few disclosure-specific restrictions in its interpretation. It is not necessary that every feature is expressed in terms of a structural limitation. Functional features may be included, provided that a skilled person would have no difficulty in providing some means of performing this function without exercising inventive skill (F-IV, 2.1). A functional feature has a scope extending to all means providing the same effect. Structurally-disclosed means within the scope of the claim are only examples (T 204/90). Independently from the language used (means + function or other), there is no presumptionsimilar to that under 35 USC 112 par. 6. Case-law has stressed a consistent application to all technical fields (engineering, chemistry, software).

Broad (functional) claims A claim may broadly define a feature in terms of its function, even where only one example of the feature has been given in the description, if the skilled reader would appreciate that other means could be used for the same function, unless the contents of the application convey the impression that such function is to be carried out in a particular way (F-IV, 6.5). The extent of generalization permissible in a claim vsthe disclosure is a matter which the examiner must judge on a case-by-case basis. An invention which opens up a whole new field is entitled to more generality in the claims than one which is concerned with advances in a known technology. A fair statement of claim is one which is not so broad that it goes beyond the invention nor yet so narrow as to deprive the applicant of a just reward for the disclosure of his invention. The applicant should be allowed to cover all obvious modifications of, equivalents to and uses of that which he has described. (F-IV-6.2)

In terms of functional claiming, the Guidelines for Examination in the EPO mention separately functional features (F-IV 6.5) and result to be achieved (F-IV-4.10), both defining an effect rather than a structure. The Guidelinesdistinguish the requirements for allowing a definition of subject-matter in terms of a result to be achieved from those for allowing a definition of subject-matter in terms of functional features (F-IV-4.10, F-IV-6.5). Such requirements are partly unified in case-law (T 68/85, T 204/90).

Two main issues arise under the doctrine and case law of the EPO in conjunction with functional claiming, namely: sufficiency of disclosure (over the broad claimed scope) under Art. 83 EPC clarity (are essential structural features missing in the claim / is the broad language supported in the description?) under Art. 84 EPC

Clarity (Art. 84 EPC) T 68/85 ( An agent for selective weed control in a quantity producing a synergistic herbicidal effect ), also in F-IV-4.10 T 204/90 ( [ ] the gripping flanges being so dimensioned as firstly to enable the device to be moved between two positions [ ] ) Claims which attempt to define the invention by a result to be achieved should not be allowed, in particular if they only amount to claiming the underlying technical problem. However, they may be allowed i. if the invention either can only be defined in such terms or cannot otherwise be defined more precisely without unduly restricting the scope of the claims, and ii. if the result is one which can be directly and positively verified by tests or proceduresadequately specified in the description or known to the person skilled in the art and which do not require undue experimentation.

Clarity (Art. 84 EPC) T 241/95 ( [ ] condition which is capable of being improved or prevented by selective occupation of the serotonin receptor ), also in F-IV-4.22 In a claim directed to a further therapeutic application of a medicament, the condition to be treated can be defined in functional termsonly if experimental tests or any testable criteria are available from the patent documents or from the common general knowledge allowing the skilled person to recognize which conditions fall within the functional definition and accordingly within the scope of the claim, in particular to determine whether the therapeutic effects are a result of the newly discovered property of the medicament. In the specific case, the selective receptor occupation was only one of the pharmacological activities of the claimed agent and no tests were available, at the application filing date, to verify whether the improvement was the result of said receptor occupation.

Sufficiency of disclosure (Art. 83 EPC) T 435/91 ( [ ] additive [ ] capable of forcing the surfactant system [ ] into hexagonal phase ) The protection covered by a patent should correspond to the technical contribution to the art made by the disclosure of the invention. Protection should not extend to subject-matter which, after reading the specification, is not at the disposal of the skilled person. It must be established whether the specification discloses a single embodiment or a concept fit for generalization which makes available to the skilled person the hosts of variants encompassed by the respective functional definition in the claim.

Sufficiency of disclosure (Art. 83 EPC) T 1063/06 ( [ ] compounds[ ] capable of stimulating the soluble guanylate [ ] ) A formulation of a claim whereby functionally-defined chemical compounds are tobefoundbymeansofanewkindofresearchtoolusingascreeningmethodset out in the description constitutes a reach-through claim which is also directed to futureinventionsbasedon theonenowbeingdisclosed andhasascopebroader than the applicant actual contribution to the art and claiming unexplored fields of research. A functional definition of a chemical compound covers all compounds possessing the capability according to the claim. In the absence of any selection rule, the skilled person, without the possibility of having recourse to his common general knowledge, must resort to extensive trial-and-error experimentation on arbitrarily selected chemical compounds to establish whether they possess the capability according to the claim; this represents for the skilled person an invitation to perform a research programme and thus an undue burden.

Sufficiency of disclosure (Art. 83 EPC) German Supreme Court (Bundesgerichtshof) X ZB 8/12 of 11 September 2013 ( [ ] inhibitors of [ ] ) The patent applicant is in principle at liberty not to limit the claimed protection to embodiments that are explicitly described in the documents originally filed, but to make certain generalizations, provided that this takes account of the legitimate desire to cover the invention in its entirety. Describing a group of compounds according to their function in a use claim is not precluded by the fact that claim wording of this kind encompasses not only compounds that are already known or are disclosed in the patent specification, but also the use of compounds that will only be provided at some time in the future; norisitprecludedbythefactthattheprovisionofsuchcompoundsmayrequire inventive activity.

Sufficiency of disclosure (Art. 83 EPC) T 544/12 ( [ ] a molecule that is a phosphorescent organometallic iridium compound [ ] ) Theopposedpatentdisclosesfivespecific structures of phosphorescent iridium complexes, but do not contain anyinformation as to how further phosphorescent iridium complexes could be identified. Theskilledpersonthuscanonlyrelyontrialanderrortofindoutwhichfurther iridium complexes, outofthealmost infinite hostofiridiumcomplexes covered by thestructural definition of claim1, are phosphorescent. The boardacknowledges inthisrespectthatareasonableamountoftrialanderrormaybeacceptable. Thispresupposes,however,thatsufficientinformationisavailablethatleadsthe skilled person directly towards success through the evaluation of initial failures (T 480/11, point 3.4 of the Reasons).

Sufficiency of disclosure (Art. 83 EPC) T 544/12 ( [ ] a molecule that is a phosphorescent organometallic iridium compound [ ] ) The board was aware of the decision of the German Supreme Court (Bundesgerichtshof) X ZB 8/12 of 11 September 2013. However, the board did not share this view. As set out in T 435/91, in order for a functional definition of a group of substances inaclaimtomeettherequirementsofart.83epc,thesubstancesfallingunderthis functional definition had all to be available to the skilled person.

When assessing substantive patentability, the scope of protection is construed by taking into account the functional definition, unless ambiguous. T 410/96 ( [ ] means for carrying out method steps ) (In the field of computer-implemented inventions) means for carrying out a function must be interpreted as means adapted to carry out the function, not merely suitable for it. T 872/09 ( [ ] wherein the sensor provides a measurement that correlates with the amount of analyte in a period of 10 seconds or less ). Legal certainty required that a claimed subject-matter cannot be regarded as novel over the prior art on the basis of an ambiguous feature (T 1049/99).

A few take aways(«global» patent drafting and enforcing) Do use functional claiming (means + function or other). Do disclose alternative structures in the description, in order for the claim to cover «equivalents» to such structures. Do provide alternative, structural wording -no nonceslike module or unit, yes controller, detector, - in multiple claims. Do bear in mind that functional language may ease, in many jurisdiction, dealing with literal vs. equivalent infringement. Do also bear in mind that «future» technical means may not fall under the functional literal wording, but may be considered in equivalent infringement where assessed at the time of the infringement.

Elisabetta Papa elisabetta.papa@sib.it Società Italiana Brevetti S.p.A. Milan, Rome, Florence, Verona Italy www.sib.it